Platelet-rich plasma for chronic lateral epicondylitis: Is one injection sufficient?
- 698 Downloads
Chronic lateral epicondylitis is generally treated using nonsurgical methods including physiotherapy and infiltrations of cortisone or platelet-rich plasma (PRP). The latter is known for its simple application as well as associated low risk of adverse events, which lend to its widespread use in treating various musculoskeletal conditions. There is limited evidence on the effectiveness of PRP injections to optimally treat chronic lateral epicondylitis. This study explored the effectiveness of single or repeated injections for patients with symptoms that spanned 6 months or more and were unresponsive to alternate conservative measures.
Methods and materials
Patients with chronic lateral epicondylitis received PRP injections in 4-week intervals that were complemented with standardized physical therapy. Patient-reported outcomes based on the patient-rated elbow evaluation (PREE), quick disabilities of the arm, shoulder and hand (qDASH), and EuroQol (five dimensions) 3-level version (EQ5D3L) questionnaires were documented at each visit including 6 months after the first injection. These outcomes were compared between patients receiving 1 vs. 2 or 3 PRP injections.
Sixty-two patients received one (n = 36) or more (n = 26) PRP injections. The mean baseline to 6-month follow-up scores of the PREE and qDASH questionnaires improved significantly from 54.0 to 23.0 and 50.3 to 20.7, respectively. The mean baseline EQ5D3L-visual analogue scale score improved from 62.5 to 82.9 by 6 months post-injection. These outcomes did not significantly differ between the patients who received varying numbers of injections.
Patients with chronic lateral epicondylitis reported significant pain relief and gain in function as well as quality of life 6 months after localized PRP treatment. A single PRP injection may be sufficient.
KeywordsEpicondylitis Platelet-rich plasma Injection Healing Elbow Patient-rated outcomes
We wish to thank all clinicians of the Schulthess Clinic upper extremity and hand team for providing cases used in the clinical evaluation part of this study as well as our study nurses Franziska Kohler and Jessica Hohn for their valuable support. The authors would like also to thank M. Wilhelmi, Ph.D. for the preparation and editing of this manuscript.
Compliance with ethical standards
Conflict of interest
- 2.Ahmad Z, Siddiqui N, Malik SS, Abdus-Samee M, Tytherleigh-Strong G, Rushton N (2013) Lateral epicondylitis: a review of pathology and management. Bone Joint J 95-B:1158–1164Google Scholar
- 3.Ries C, Franke S, Dietrich F, Jakubowitz E, Dehlinger F, Hollinger B (2013) Transosseous refixation of the common extensor muscle tendons in chronic lateral epicondylitis with and without additional reconstruction of the LUCL—a retrospective evaluation of 101 patients. Z Orthop Unfall 151:296–301CrossRefPubMedGoogle Scholar
- 20.Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T (2010) Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med 38:255–262CrossRefPubMedGoogle Scholar
- 24.Beitzel K, McCarthy MB, Cote MP, Apostolakos J, Russell RP, Bradley J, ElAttrache NS, Romeo AA, Arciero RA, Mazzocca AD (2013) The effect of ketorolac tromethamine, methylprednisolone, and platelet-rich plasma on human chondrocyte and tenocyte viability. Arthroscopy 29:1164–1174CrossRefPubMedGoogle Scholar
- 27.Angst F, Goldhahn J, Drerup S, Flury M, Schwyzer HK, Simmen BR (2009) How sharp is the short QuickDASH? A refined content and validity analysis of the short form of the disabilities of the shoulder, arm and hand questionnaire in the strata of symptoms and function and specific joint conditions. Qual Life Res 18:1043–1051CrossRefPubMedGoogle Scholar